Eisai
4523.T
#2011
Rank
C$11.48 B
Marketcap
$40.24
Share price
-1.22%
Change (1 day)
-28.59%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

EPS for Eisai (4523.T)

EPS in 2023 (TTM): $2.95

According to Eisai's latest financial reports the company's current EPS (TTM) is $3.10. In 2022 the company made an earnings per share (EPS) of $2.27 a decrease over its 2021 EPS that were of $10.09.

EPS history for Eisai from 2009 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$2.9529.73%
2022$2.27-77.48%
2021$10.09-41.88%
2020$17.36-0.94%
2019$17.5252.59%
2018$11.48124.17%
2017$5.12-49.42%
2016$10.1337.08%
2015$7.39-11.75%
2014$8.37-3.23%
2013$8.65-18.56%
2012$10.63-15.51%
2011$12.58-3.75%
2010$13.07-1.36%
2009$13.25